Overview
Ischemic hepatitis is a rare condition characterized by acute liver injury due to severe and persistent hepatic hypoperfusion, often associated with a marked elevation in transaminases levels, typically more than 20 times the normal value. It has a high mortality rate, estimated at around 60%, and can be triggered by various etiologies, including severe cardiac dysfunction 1.Diagnosis
Key Diagnostic Criteria: Rapid and marked elevation in transaminases (>20 times normal) secondary to hepatic hypoperfusion 1.
Recommended Tests: Liver function tests (transaminases, bilirubin), imaging studies (CT, MRI) to assess for underlying causes, and possibly liver biopsy in complex cases 1.
Grading: Not explicitly detailed in provided abstracts; clinical severity often correlates with the degree of transaminase elevation and presence of complications 1.Management
First-Line Treatments: Address and treat the underlying cause (e.g., cardiac dysfunction, shock) 1.
Adjunctive Treatments: Supportive care including fluid management, monitoring for liver failure, and potential use of N-acetylcysteine in severe cases, though specific dosing is not detailed 1.
Specific Drug Classes: No specific drug classes or doses are mentioned beyond addressing the primary etiology 1.Special Populations
Elderly: Increased susceptibility and severity noted in elderly patients, as exemplified by the case report 1.
Comorbidities: Severe cardiac dysfunction is highlighted as a significant comorbidity leading to ischemic hepatitis 1.Key Recommendations
Prompt identification and treatment of the underlying cause (e.g., cardiac dysfunction) are critical to improve outcomes (Evidence: Expert opinion 1).
Monitor liver function closely with serial transaminase levels and bilirubin to guide management (Evidence: Expert opinion 1).
Supportive care measures should be implemented early to manage complications and maintain hemodynamic stability (Evidence: Expert opinion 1).References
1 Aliaga Ramos JJ, Espinoza-Ríos J, Valenzuela Granados V, Pinto Valdivia J, Bussalleu Rivera A. [Fulminating ischemic hepatitis induced by severe cardiac dysfunction: case report]. Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru 2018. link